Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 38 of Longeveron Inc.'s SEC filings and found 19 warrant series, 1 convertible, 1 ATM program, 2 shelf registrations, 2 S-1 registrations and 1 completed offering on file for LGVN. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 3, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
OSRHOSR Holdings, Inc.
IMNNImunon, Inc.
PCSAProcessa Pharmaceuticals, Inc.
RVPHReviva Pharmaceuticals Holdings, Inc.
ADXNAddex Therapeutics Ltd American Depositary Shares
NIKINiki BioSolutions, Inc.
PULMPulmatrix, Inc.
SKYESkye Bioscience, Inc.
ACXPAcurx Pharmaceuticals, Inc.
CNSPCNS Pharmaceuticals, Inc.
SNTISenti Biosciences, Inc.
XBIOXenetic Biosciences, Inc.
CANFCan-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares
CDIOCardio Diagnostics Holdings, Inc.
CELZCreative Medical Technology Holdings, Inc.